Results 81 to 90 of about 3,018 (199)

Bevacizumab in HER2neu Negative Locally Recurrent and Metastatic Breast Cancer: The BHerN Review

Acta Medica Philippina, 2015
...
Mary Ondinee U. Manalo, Mark Anthony E. Agana, Corazon A Ngelangel   +2 more
openaire   +2 more sources

Tomotherapy in synchronous and metachronous bilateral breast cancer: Clinical experience

Journal of Applied Clinical Medical Physics, Volume 25, Issue 7, July 2024.
Abstract Purpose of study The objective of this research is to present our firsthand experience and provide up‐to‐date data for the further study of cases involving simultaneous breast irradiation using helical Tomotherapy, ©Accuray Inc. Methods The radical treatment options for bilateral breast cancer are surgery, chemotherapy, and radiation therapy ...
Yernar Orda, Tanzhas Shayakhmetov, Saniya Baiturova, Daulet Berikbol, Rauan Otynshiyev, Aigul Brimova, Bolat Saktashev, Ainur Baisalbayeva, Ainur Samigatova   +8 more
wiley   +1 more source

CD10-A new prognostic stromal marker in breast carcinoma, its utility, limitations and role in breast cancer pathogenesis

Indian Journal of Pathology and Microbiology, 2014
Background and Aims: Breast cancer is one of the leading causes of mortality in Indian women. Although breast cancer is an epithelial malignancy, stroma plays a key role in its development and pathogenesis.
Sayantan H Jana, Bharti M Jha, Chandni Patel, Dipan Jana, Anshul Agarwal   +4 more
doaj   +1 more source

Caso clínico de cáncer de mama localmente avanzado [PDF]

, 2016
Se presenta un caso clínico de cáncer de mama en el que existe invasión de la cadena mamaria interna sin previa afectación axilar. Se trata de una mujer de 49 años que mediante autoexploración se detecta un nódulo en la mama derecha.
Moreno Pulido, Silvia, Ruiz Soriano, María   +1 more
core  

Circulating tumour cells: insights into tumour heterogeneity [PDF]

, 2013
Tumour heterogeneity is a major barrier to cure breast cancer. It can exist between patients with different intrinsic subtypes of breast cancer or within an individual patient with breast cancer.
Hayes, D. F., Paoletti, C.
core   +1 more source

Assessment of HER2NEU Gene Amplication by Flourescence in Situ Hybridization in Breast Carcinoma with Equivocal Findings on Immunostaining

Pakistan Armed Forces Medical Journal, 2023
Objective: To determine the frequency of HER2/neu gene amplification by fluorescence in situ hybridization in Breast carcinoma patients with equivocal findings and to see its association with different clinicopathological features. Study Design: Cross-sectional study. Place and Duration of study: Medical Oncology Department, Jinnah Postgraduate Medical
Asra Taj, null Ghulam Haider, null Maliha Ashfaq, null Mahnoor Ahsan, null Khalil Ahmed, null Wish Hal Sundar   +5 more
openaire   +1 more source

A Genome‐Wide Association Study of Endoxifen Serum Concentrations and Adjuvant Tamoxifen Efficacy in Early‐Stage Breast Cancer Patients

Clinical Pharmacology &Therapeutics, Volume 116, Issue 1, Page 155-164, July 2024.
Tamoxifen is part of the standard of care of endocrine therapy for adjuvant treatment of breast cancer. However, survival outcomes with tamoxifen are highly variable. The concentration of endoxifen, the 30–100 times more potent metabolite of tamoxifen and bioactivated by the CYP2D6 enzyme, has been described as the most relevant metabolite of tamoxifen
Anabel Beatriz Sanchez‐Spitman, Stefan Böhringer, Vincent Olaf Dezentjé, Hans Gelderblom, Jesse Joachim Swen, Henk‐Jan Guchelaar   +5 more
wiley   +1 more source

Comparing the Prognostic Value of PTEN and Akt Expression with the Mitotic Activity Index in Adjuvant Chemotherapy-Treated Node-Negative Breast Cancer patients aged <55 years

Cellular Oncology, 2007
Background: The prognostic value of the PI3K/Akt/mTOR pathway and PTEN in invasive breast cancer (IBC) is controversial. Cell proliferation, especially the Mitotic Activity Index (MAI), is strongly prognostic in lymph node-negative (LNneg) invasive ...
Emiel A. M. Janssen, Håvard Søiland, Ivar Skaland, Einar Gudlaugson, Kjell H. Kjellevold, Arne Nysted, Jon-Arne Søreide, Jan P. A. Baak   +7 more
doaj   +1 more source

Pure mucinous adenocarcinoma of the breast with the rare lymphoplasmacytic infiltration: A case report with review of literature

Clinical Case Reports, Volume 12, Issue 4, April 2024.
Shows the progression of the patient pre operative to after the procedure (Lumpectomy) was performed. Key Clinical Message A unique ER/PR‐positive mucinous adenocarcinoma of breast but CK7/CK20 negativity. A rare finding of Lymphoplasmacytic Infiltration is noted.
Yash Hasmukhbhai Prajapati, Vishal Bhabhor, Kahan Samirkumar Mehta, Mithoon Barot, Husen Boriwala, Mohamed Omar   +5 more
wiley   +1 more source

HER-2/neu overexpression in breast cancer

مجلة كلية الطب, 2010
Background: In breast carcinoma, amplification &/or over-expression of HER-2/neu has been associated with a group of unfavorable prognostic factors. The Food & Drug Administration Agency approved Trastuzumab (Herceptin) for the therapy of metastatic ...
Rana S. Aziz, Nabeel W. Rasheed
doaj   +1 more source